After more than two years of selling the Gardasil vaccine as a way of protecting girls and young women against cervical cancer, Merck is asking federal drug regulators to allow the vaccine's use in boys and men between the ages of 9 and 26.
The drugmaker is counting on the expanded use to boost sales of Gardasil, which have flattened after a quick start. Getting that boost, however, may prove difficult.
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.